Related references
Note: Only part of the references are listed.Cancer Risk After Exposure to Treatments for Ovulation Induction
R. Calderon-Margalit et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Ovulation-stimulation drugs and cancer risks: a long-term follow-up of a British cohort
I. dos Santos Silva et al.
BRITISH JOURNAL OF CANCER (2009)
Use of fertility drugs and risk of ovarian cancer: Danish population based cohort study
Allan Jensen et al.
BMJ-BRITISH MEDICAL JOURNAL (2009)
Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women
Allan Jensen et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Malignant melanoma risk after exposure to fertility drugs: results from a large Danish cohort study
Charlotte Gerd Hannibal et al.
CANCER CAUSES & CONTROL (2008)
Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study
G. Hannibal et al.
HUMAN REPRODUCTION (2008)
Risk of breast cancer after exposure to fertility drugs: Results from a large Danish cohort study
Allan Jensen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Uterine cancer after use of clomiphene citrate to induce ovulation
MD Althuis et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Assisted reproductive technology in Europe, 2000. Results generated from European registers by ESHRE
AN Andersen et al.
HUMAN REPRODUCTION (2004)
The effects of tamoxifen on the female genital tract
E Senkus-Konefka et al.
CANCER TREATMENT REVIEWS (2004)
Cancer incidence following treatment for infertility at a clinic in the UK
P Doyle et al.
HUMAN REPRODUCTION (2002)
Cancer incidence in a cohort of infertile women who underwent in vitro fertilization
J Dor et al.
FERTILITY AND STERILITY (2002)
Ovulation induction and risk of endometrial cancer: a pilot study
A Benshushan et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2001)
A pharmacological review of selective oestrogen receptor modulators
SR Goldstein et al.
HUMAN REPRODUCTION UPDATE (2000)